This is a real-world medical entrance exam question, please give the true answer based on the question and selection. Topic name: None, Subject name: Pharmacology
Valsartan differs from ramipril in the following respect: 
Select and explain. 
A. It does not potentiate bradykinin, B. It can be safely administered to a patient with bilateral renal artery stenosis, C. It impairs carbohydrate tolerance, D. It does not have fetopathic potential
A: It does not potentiate bradykinin
Answer: A: It does not potentiate bradykinin 
Explanation: None